IN VITRO AND IN VIVO EFFECT OF AN ORAL IRON CHELATOR DEFERASIROX IN MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Choi, C. W. [1 ]
Kim, J. L. [2 ]
Kang, H. N. [2 ]
Kang, M. H. [2 ]
Yoo, Y. A. [2 ]
机构：
[1] Korea Univ, Guru Teg Bahadur Hosp, Seoul, South Korea
[2] Korea Univ, Coll Med, Grad Sch Med, Seoul 136705, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
收藏
页码：268 / 268
页数：1
相关论文
共 50 条
  • [31] EFFECT OF MULTIPOTENT MESENCHYMAL STROMA CELLS (MSC) ON ACUTE MYELOID LEUKEMIA (AML) CELLS IN VITRO AND IN VIVO
    Schelker, Roland C.
    Mueller, Gunnar
    Hart, Christina
    Klatt, Sabine
    Herr, Wolfgang
    Grassinger, Jochen
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S94 - S94
  • [32] The effect of the iron chelator Deferasirox in combination with Cisplatin chemotherapy against lung carcinoma
    Torres, Priscilla M. Rodriguez
    Perez, Daraishka
    Ferrer, Yancy
    Delgado, Yamixa
    FASEB JOURNAL, 2022, 36
  • [33] Synergistic effects of Deferasirox and Imatinib in chronic myeloid leukemia cells
    Kim, Dae Sik
    Kang, Myoung Hee
    Na, Yoo Jin
    Kim, Jung Lim
    Kim, Bo Ram
    Park, Kyong Hwa
    Oh, Sang Cheul
    Seo, Jae Hong
    Choi, Chul Won
    Kim, Jun Suk
    CANCER RESEARCH, 2014, 74 (19)
  • [34] Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia: the ESCALATOR study
    Taher, Ali
    El-Beshlawy, Amal
    Elalfy, Mohsen S.
    Al Zir, Kusai
    Daar, Shahina
    Habr, Dany
    Kriemler-Krahn, Ulrike
    Hmissi, Abdel
    Al Jefri, Abdullah
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (06) : 458 - 465
  • [35] Can oral iron deferasirox chelator alone reduce the mortality by cardiac overload in Thalassemia Major?
    Bachir, Dora
    HEMATOLOGIE, 2010, 16 (06): : 404 - 406
  • [36] ROLE OF DEFERASIROX, AN ORAL IRON CHELATOR IN PREVENTION OF ISCHEMIC REPERFUSION MYOCARDIAL INJURY IN ALBINO RABBITS
    Gambhir, G.
    Gupta, A. K.
    Agrawal, P.
    Kushwaha, V.
    Singh, A.
    Jain, I. P.
    Singh, A. N.
    Tripathi, P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (06):
  • [37] Effectiveness of Oral Iron Chelator Treatment with Deferasirox in an Aceruloplasminemia Patient with a Novel Ceruloplasmin Gene Mutation
    Suzuki, Yasuhiro
    Yoshida, Kosuke
    Aburakawa, Yoko
    Kuroda, Kenji
    Kimura, Takashi
    Terada, Tatsuhiro
    Kono, Satoshi
    Miyajima, Hiroaki
    Yahara, Osamu
    INTERNAL MEDICINE, 2013, 52 (13) : 1527 - 1530
  • [38] The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin
    Hasinoff, BB
    Patel, D
    Wu, X
    FREE RADICAL BIOLOGY AND MEDICINE, 2003, 35 (11) : 1469 - 1479
  • [39] The effect of Go6976 on chronic myeloid leukemia in vitro and in vivo
    Cao, Zhen-Rui
    Chen, Xiao-Peng
    Feng, Min
    Hou, Yun-Long
    Li, Yan
    Hu, Xiao-Lei
    Huang, Zheng-Lan
    Hu, Jing
    HEMATOLOGY, 2021, 26 (01) : 543 - 551
  • [40] Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro
    Imanishi, Satoshi
    Takahashi, Ryoko
    Ohsuga, Miho
    Ohyashiki, Kazuma
    Ohyashiki, Junko H.
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1601 - 1602
12345